Antidepressant use with NSAIDs may increase risk of intracranial bleed Combination therapy riskier in males, similar risk with all antidepressant classes Canadian stroke best practice recommendations: 2015 updateStronger focus on managing poststroke depression, vascular cognitive impairment and fatigue. Clinical Feature: Getting to the heart of it How pharmacists can improve adherence in patients with cardiovascular disease. New research finds pharmacist prescribing significantly reduces hypertension Evidence from RxACTION study shows it is time to move from research to implementation, says Ross Tsuyuki. Trial trumpets LDL lowering Does sitagliptin increase cardiovascular risk in diabetes patients? New study shows no apparent increased risk of major adverse cardiovascular events or hospitalization for heart failure. Inaugural Peter Munk Chair in structural heart disease intervention announced Device treats heart failure via the spinal cord Technique has produced mixed results in trials Manitoba Health says pediatric cardiac care program not likely to be revived New simplified lipid pathway for reducing cardiovascular risk in primary care Alberta TOP clinical practice guideline streamlines statin prescribing and reduces lipid monitoring. First Previous 48 49 50 51 52 Next Last
